Skip to main content
Top
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Research article

The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer–a cross-sectional study of patient characteristics and cancer probability

Authors: Mads Lind Ingeman, Morten Bondo Christensen, Flemming Bro, Søren T. Knudsen, Peter Vedsted

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Background

A Danish cancer pathway has been implemented for patients with serious non-specific symptoms and signs of cancer (NSSC-CPP). The initiative is one of several to improve the long diagnostic interval and the poor survival of Danish cancer patients. However, little is known about the patients investigated under this pathway. We aim to describe the characteristics of patients referred from general practice to the NSSC-CPP and to estimate the cancer probability and distribution in this population.

Methods

A cross-sectional study was performed, including all patients referred to the NSSC-CPP at the hospitals in Aarhus or Silkeborg in the Central Denmark Region between March 2012 and March 2013. Data were based on a questionnaire completed by the patient’s general practitioner (GP) combined with nationwide registers. Cancer probability was the percentage of new cancers per investigated patient. Associations between patient characteristics and cancer diagnosis were estimated with prevalence rate ratios (PRRs) from a generalised linear model.

Results

The mean age of all 1278 included patients was 65.9 years, and 47.5 % were men. In total, 16.2 % of all patients had a cancer diagnosis after six months; the most common types were lung cancer (17.9 %), colorectal cancer (12.6 %), hematopoietic tissue cancer (10.1 %) and pancreatic cancer (9.2 %). All patients in combination had more than 80 different symptoms and 51 different clinical findings at referral. Most symptoms were non-specific and vague; weight loss and fatigue were present in more than half of all cases. The three most common clinical findings were ‘affected general condition’ (35.8 %), ‘GP’s gut feeling’ (22.5 %) and ‘findings from the abdomen’ (13.0 %). A strong association was found between GP-estimated cancer risk at referral and probability of cancer.

Conclusions

In total, 16.2 % of the patients referred through the NSSC-CPP had cancer. They constituted a heterogeneous group with many different symptoms and clinical findings. The GP’s gut feeling was a common reason for referral which proved to be a strong predictor of cancer. The GP’s overall estimation of the patient’s risk of cancer at referral was associated with the probability of finding cancer.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127–38.CrossRefPubMedPubMedCentral Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127–38.CrossRefPubMedPubMedCentral
3.
go back to reference De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5-a population-based stud. Lancet Oncol. 2014;15(1):23–34.CrossRefPubMed De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5-a population-based stud. Lancet Oncol. 2014;15(1):23–34.CrossRefPubMed
4.
go back to reference Torring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary care. Eur J Cancer. 2013;49(9):2187–98.CrossRefPubMed Torring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary care. Eur J Cancer. 2013;49(9):2187–98.CrossRefPubMed
5.
go back to reference Torring ML, Frydenberg M, Hamilton W, Hansen RP, Lautrup MD, Vedsted P. Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol. 2012;65(6):669–78.CrossRefPubMed Torring ML, Frydenberg M, Hamilton W, Hansen RP, Lautrup MD, Vedsted P. Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol. 2012;65(6):669–78.CrossRefPubMed
8.
go back to reference Nielsen TN, Hansen RP, Vedsted P. Symptom presentation in cancer patients in general practice. Ugeskr Laeger. 2010;172(41):2827–31.PubMed Nielsen TN, Hansen RP, Vedsted P. Symptom presentation in cancer patients in general practice. Ugeskr Laeger. 2010;172(41):2827–31.PubMed
9.
go back to reference Hansen RP. Delay in the diagnosis of cancer PhD thesis. Aarhus: Faculty of Health Sciences, University of Aarhus; 2008. Hansen RP. Delay in the diagnosis of cancer PhD thesis. Aarhus: Faculty of Health Sciences, University of Aarhus; 2008.
10.
go back to reference Allgar VL, Neal RD. General practictioners’ management of cancer in England: secondary analysis of data from the National Survey of NHS Patients-Cancer. Eur J Cancer Care (Engl). 2005;14(5):409–16.CrossRef Allgar VL, Neal RD. General practictioners’ management of cancer in England: secondary analysis of data from the National Survey of NHS Patients-Cancer. Eur J Cancer Care (Engl). 2005;14(5):409–16.CrossRef
11.
go back to reference Christensen KG, Fenger-Gron M, Flarup KR, Vedsted P. Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis-a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res. 2012;12(1):224.CrossRefPubMedPubMedCentral Christensen KG, Fenger-Gron M, Flarup KR, Vedsted P. Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis-a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res. 2012;12(1):224.CrossRefPubMedPubMedCentral
13.
go back to reference Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106(7):126210–1267.CrossRef Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106(7):126210–1267.CrossRef
14.
go back to reference The National Board oH. National Cancer Plan II Denmark National Board of Health recommendations for improving cancer healthcare services. Copenhagen: The National Board of Health; 2005. The National Board oH. National Cancer Plan II Denmark National Board of Health recommendations for improving cancer healthcare services. Copenhagen: The National Board of Health; 2005.
15.
go back to reference Department oH. The NHS Cancer Plan. A plan for investment, A plan for reform. London: Department of Health; 2000. Department oH. The NHS Cancer Plan. A plan for investment, A plan for reform. London: Department of Health; 2000.
16.
go back to reference Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-A national Danish project. Health Policy. 2012;105(1):65–70.CrossRefPubMed Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-A national Danish project. Health Policy. 2012;105(1):65–70.CrossRefPubMed
18.
go back to reference Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-A national Danish project. Health Policy. 2012;105(1):65–70.CrossRefPubMed Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-A national Danish project. Health Policy. 2012;105(1):65–70.CrossRefPubMed
20.
go back to reference Neal RD, Din NU, Hamilton W, Ukoumunne OC, Carter B, Stapley S, et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer. 2014;110(3):584–92.CrossRefPubMed Neal RD, Din NU, Hamilton W, Ukoumunne OC, Carter B, Stapley S, et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer. 2014;110(3):584–92.CrossRefPubMed
21.
go back to reference Jensen H, Torring ML, Olesen F, Overgaard J, Vedsted P. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. BMC Cancer. 2014;14(1):636–2407. 14-636.CrossRefPubMedPubMedCentral Jensen H, Torring ML, Olesen F, Overgaard J, Vedsted P. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. BMC Cancer. 2014;14(1):636–2407. 14-636.CrossRefPubMedPubMedCentral
22.
go back to reference Meechan D, Gildea C, Hollingworth L, Richards MA, Riley D, Rubin G. Variation in use of the 2-week referral pathway for suspected cancer: A cross-sectional analysis. Br J Gen Pract. 2012;62(602):590–7.CrossRef Meechan D, Gildea C, Hollingworth L, Richards MA, Riley D, Rubin G. Variation in use of the 2-week referral pathway for suspected cancer: A cross-sectional analysis. Br J Gen Pract. 2012;62(602):590–7.CrossRef
23.
go back to reference Vedsted P, Olesen F. A differentiated approach to referrals from general practice to support early cancer diagnosis - the Danish three-legged strategy. Br J Cancer. 2015;112(Suppl):S65–9.CrossRefPubMedPubMedCentral Vedsted P, Olesen F. A differentiated approach to referrals from general practice to support early cancer diagnosis - the Danish three-legged strategy. Br J Cancer. 2015;112(Suppl):S65–9.CrossRefPubMedPubMedCentral
24.
go back to reference Hamilton W. The CAPER studies: five case–control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101 Suppl 2:S80–6. S80-S86.CrossRefPubMedPubMedCentral Hamilton W. The CAPER studies: five case–control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101 Suppl 2:S80–6. S80-S86.CrossRefPubMedPubMedCentral
25.
go back to reference Pedersen KM, Andersen JS, Sondergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012;25 Suppl 1:S34–8.CrossRefPubMed Pedersen KM, Andersen JS, Sondergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012;25 Suppl 1:S34–8.CrossRefPubMed
26.
27.
go back to reference Soler JK, Okkes I, Wood M, Lamberts H. The coming of age of ICPC: celebrating the 21st birthday of the International Classification of Primary Care. Fam Pract. 2008;25(4):312–7.CrossRefPubMed Soler JK, Okkes I, Wood M, Lamberts H. The coming of age of ICPC: celebrating the 21st birthday of the International Classification of Primary Care. Fam Pract. 2008;25(4):312–7.CrossRefPubMed
28.
go back to reference Stolper E, Van RP, Dinant GJ. The ‘sense of alarm’ (‘gut feeling’) in clinical practice. A survey among European general practitioners on recognition and expression. Eur J Gen Pract. 2010;16(2):72–4.CrossRefPubMed Stolper E, Van RP, Dinant GJ. The ‘sense of alarm’ (‘gut feeling’) in clinical practice. A survey among European general practitioners on recognition and expression. Eur J Gen Pract. 2010;16(2):72–4.CrossRefPubMed
30.
go back to reference Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull. 1997;44:535–9.PubMed Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull. 1997;44:535–9.PubMed
31.
go back to reference Danish National Board of Health. The Cancer Registry 2009 in Danish. 2010. p. 1–55. Danish National Board of Health. The Cancer Registry 2009 in Danish. 2010. p. 1–55.
32.
go back to reference Larsen MB, Jensen H, Hansen RP, Olesen F, Vedsted P. Identification of patients with incident cancers using administrative registry data. Dan Med J. 2014;61(2):A4777.PubMed Larsen MB, Jensen H, Hansen RP, Olesen F, Vedsted P. Identification of patients with incident cancers using administrative registry data. Dan Med J. 2014;61(2):A4777.PubMed
33.
go back to reference Moth G, Vedsted P, Olesen F. Kontakt- og sygdomsmønsteret i almen praksis. KOS 2008. Aarhus: Forskningsenheden for Almen Praksis i Aarhus, Aarhus Universitet; 2010. Moth G, Vedsted P, Olesen F. Kontakt- og sygdomsmønsteret i almen praksis. KOS 2008. Aarhus: Forskningsenheden for Almen Praksis i Aarhus, Aarhus Universitet; 2010.
34.
go back to reference Jensen H, Torring ML, Larsen MB, Vedsted P. Existing data sources for clinical epidemiology: Danish Cancer in Primary Care cohort. Clin Epidemiol. 2014;6:237–46.CrossRefPubMedPubMedCentral Jensen H, Torring ML, Larsen MB, Vedsted P. Existing data sources for clinical epidemiology: Danish Cancer in Primary Care cohort. Clin Epidemiol. 2014;6:237–46.CrossRefPubMedPubMedCentral
35.
go back to reference Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1174–82.CrossRefPubMedPubMedCentral Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1174–82.CrossRefPubMedPubMedCentral
36.
go back to reference Edgren G, Liang L, Adami HO, Chang ET. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012;27(3):187–96.CrossRefPubMed Edgren G, Liang L, Adami HO, Chang ET. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol. 2012;27(3):187–96.CrossRefPubMed
37.
go back to reference Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11(1):284.CrossRefPubMedPubMedCentral Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11(1):284.CrossRefPubMedPubMedCentral
38.
go back to reference Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer. 2013;108(3):686–90.CrossRefPubMedPubMedCentral Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer. 2013;108(3):686–90.CrossRefPubMedPubMedCentral
39.
go back to reference Guldbrandt LM, Fenger-Gron M, Folkersen BH, Rasmussen TR, Vedsted P. Reduced specialist time with direct computed tomography for suspected lung cancer in primary care. Dan Med J. 2013;60(12):A4738.PubMed Guldbrandt LM, Fenger-Gron M, Folkersen BH, Rasmussen TR, Vedsted P. Reduced specialist time with direct computed tomography for suspected lung cancer in primary care. Dan Med J. 2013;60(12):A4738.PubMed
40.
go back to reference Bosch X, Escoda O, Nicolas D, Coloma E, Fernandez S, Coca A, et al. Primary care referrals of patients with potentially serious diseases to the emergency department or a quick diagnosis unit: a cross-sectional retrospective study. BMC Fam Pract. 2014;15(1):75.CrossRefPubMedPubMedCentral Bosch X, Escoda O, Nicolas D, Coloma E, Fernandez S, Coca A, et al. Primary care referrals of patients with potentially serious diseases to the emergency department or a quick diagnosis unit: a cross-sectional retrospective study. BMC Fam Pract. 2014;15(1):75.CrossRefPubMedPubMedCentral
41.
go back to reference Hjertholm P, Moth G, Ingeman ML, Vedsted P. Predictive values of GPs’ suspicion of serious disease: a population-based follow-up study. Br J Gen Pract. 2014;64(623):e346–53.CrossRefPubMedPubMedCentral Hjertholm P, Moth G, Ingeman ML, Vedsted P. Predictive values of GPs’ suspicion of serious disease: a population-based follow-up study. Br J Gen Pract. 2014;64(623):e346–53.CrossRefPubMedPubMedCentral
42.
go back to reference Rubin G, Vedsted P, Emery J. Improving cancer outcomes: Better access to diagnostics in primary care could be critical. 2011. p. 317–8. Rubin G, Vedsted P, Emery J. Improving cancer outcomes: Better access to diagnostics in primary care could be critical. 2011. p. 317–8.
43.
go back to reference Baughan P, Keatings J, O’Neill B. Urgent suspected cancer referrals from general practice: audit of compliance with guidelines and referral outcomes. Br J Gen Pract. 2011;61(592):700–6.CrossRef Baughan P, Keatings J, O’Neill B. Urgent suspected cancer referrals from general practice: audit of compliance with guidelines and referral outcomes. Br J Gen Pract. 2011;61(592):700–6.CrossRef
Metadata
Title
The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer–a cross-sectional study of patient characteristics and cancer probability
Authors
Mads Lind Ingeman
Morten Bondo Christensen
Flemming Bro
Søren T. Knudsen
Peter Vedsted
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1424-5

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine